BioCity Scotland as part of their series of events for life science entrepreneurs organised #FundBio14 in October where delegates were addressed by some of the leading angel investors and crowd funders for the sector. Here is a snippet of what they and other experts had to say in this short video.
Park provides BBRO with ideal laboratory space for new aphid growth facilities to spearhead research and development of future virus yellows resistant sugar beet varieties, cementing the organisation’s position as the leading European authority in this field
Registrations are now invited for those looking to attend the opening event which will be held on Wednesday 14th January 2015 at the Adastral Park research facility and focusses on the Information and Communication Technology (ICT) sector.
Please join us for the next Edinburgh BioQuarter networking event, featuring
Harry Statford OBE, founder of Shire Pharmaceuticals and ProStrakan.
This free event will take place on Tuesday 18 November from 5pm in Wellcome Trust Auditorium, Queen's Medical Research Institute at the BioQuarter. Doors open for registration at 5pm with the formalities starting at 5.30pm.
Begbroke Science Park (BSP) has announced that it will sponsor the Innovation & Creativity Award at the Cherwell Business Awards for a second year, and has once again joined the organising committee.
Discovery Park is inviting small businesses to take a look at its new startup zone, as part of the open day on 4 November.
Oxford Gene Technology (OGT), the molecular genetics company, has announced it is initiating a clinical trial of a new non-invasive prenatal test (NIPT) for Down’s syndrome.
It’s microarray technology has significant advantages over other methods, reducing waiting times for results and costs.
Biologically positioned company AbBaltis has recorded outstanding growth at the end of only its fourth financial year in business. Based on Kent Science Park, AbBaltis serves In Vitro Diagnostic market by offering innovative, reliable, and quality products. The company also supplies a wide variety of Disease State Plasma and Residual Clinical Samples to companies worldwide.
Intel-GE Care Innovations™, a pioneer in connecting the care continuum to the home, and Kinesis Health Technologies, the University College Dublin (UCD) medical device spin-out company, announced today a partnership to market and distribute QTUG™, a Mobility and Falls Risk assessment technology.
The partnership focuses on helping the healthcare and senior living communities more proactively and aggressively prevent falls. QTUG™ is designed to give a more comprehensive view of an individual’s risk of falling.